 - HIV RNA 500 copiesml on a regimen of two nucleoside reverse transcriptase inhibitors NRTIs and either one protease inhibitor PI or one nonnucleoside reverse transcriptase inhibitor NNRTI for 6 months prior to study entry - HIV RNA 50 copiesml at study screening 